Response to the letter to the editor on “an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy”
Year: 2019
Type: letter
Abstract: We thank the authors of the recent letter to the editor [1] for their thoughtful review of our article, ‘An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatmen...
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funder: Alnylam Pharmaceuticals
OpenAlex ID: W2946412134